Clinical trials recruiting in Henan, China

Phase breakdown

Conditions recruiting in Henan, China

Recruiting trials in Henan, China

• Carbon Nanoparticle-Loaded Iron in the Treatment of Advanced Solid Tumor
  NCT07433283 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Chinese Psoriasis Real World Evidence Research
  NCT04465838 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female)
• DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
  NCT06953089 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Darsilide Combined With AI, Trastuzumab and Patuzumab in the Neoadjuvant Treatment of HR+/HER2+ Breast Cancer
  NCT06276868 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female
• Efficacy and Safety of Prepectoral Prosthesis Immediate One-Stage Breast Reconstruction Versus Two-Stage Expander/Prosthesis Reconstruction in Postoperative Adjuvant Radiotherapy Breast Cancer Patients: A Prospective, Single-Center, Cohort Study
  NCT07037576 · Phase: Not specified · Ages: 18 Years to 70 Years · Sex: Female
• Exhaled Breath Condensate Biomarkers in CARAS
  NCT06573450 · Phase: Not specified · Ages: 18 Years to 80 Years · Sex: All (male and female)
• Hydronidone Capsules in Long-term Treatment in Patients With Chronic Viral Hepatitis B Liver Fibrosis
  NCT05905172 · Phase: Phase 3 · Ages: 18 Years to 65 Years · Sex: All (male and female)
• Phase 3 Study of Toripalimab Alone or in Combination With Tifcemalimab as Consolidation Therapy in Patients With Limited-stage Small Cell Lung Cancer (LS-SCLC)
  NCT06095583 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female)
• Prognostic Value of Neurometabolic Networks in CRC (PVNM-CRC)
  NCT06930586 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female)
• Rinatabart Sesutecan (Rina-S, PRO1184, GEN1184) for Advanced Solid Tumors (GCT1184-01/ PRO1184-001)
  NCT05579366 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors
  NCT04930432 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female)
• Treatment of Irinotecan Hydrochloride Liposome Injection II in China: a Real World Study of Pancreatic Cancer Patients
  NCT06375473 · Phase: Not specified · Ages: 18 Years to 100 Years · Sex: All (male and female)

Common questions

How many clinical trials are recruiting in Henan, China?

12 recruiting trials have at least one study site in Henan, China.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.